postprandial metabolites of meal challenge test in diabetes state

Conditions: Type2 Diabetes; Postprandial Hyperglycemia

Summary: postprandial hyperglycemia is a hallmark feature of type 2 diabetes mellitus (t2d), and persistent elevated glycemic level has shown to be strongly associated with oxidative stress, and a risk factor for cardiovascular disease (cvd). in malaysia, the glycemic control is poor and patients with t2d commonly experiencing persistent postprandial hyperglycemia (12.7 mmol/l). a low glycemic index (gi) meal has been reported to reduce postprandial glycemia and insulin concentration in patients with t2d. metabolomics technique can be used to identify comprehensive metabolites in response to different diet. till date, local scientific data documented on the role and interaction between diet and metabolites for the malaysian patients with t2d is unknown. this study is to determine the postprandial metabolomic effect of low and high gi meals in patients with t2d using the nmr-based metabolomics approach. then, patients with t2d will be assigned for 14 days of chronic feeding trial intervention. this study will help to establish local baseline data and understand the impact of meal-patterns on metabolic and metabolite at postprandial responses.

despite targeting to optimize fasting blood glucose and lowering hba1c level, postprandial hyperglycemia needs to be highlighted in the management of type 2 diabetes mellitus (t2d). postprandial hyperglycemia is the rapid and significant rise in blood glucose level above 7.8 mmol/l 2 hour after meal ingestion. it is strongly associated with oxidative stress and a risk factor for cardiovascular disease (cvd). in malaysia, the glycemic control is poor, and patients with t2d commonly experiencing persistent hyperglycemia (12.7 mmol/l), which is the highest concentration in south east asia region. nonetheless, a low glycemic index (gi) meal has been reported to reduce postprandial glycemia and insulin concentration in patients with t2d but the metabolite responsiveness following low gi meal is not studied yet. the study of the postprandial state is imperative as it reveals multiple aspects of metabolic health that would not be apparent from solely studying the fasting parameters. hence, the objective of this study is to determine the postprandial metabolomic effects of low and high gi meals in patients with t2d using the nmr-based metabolomics approach. then, the postprandial metabolic response and metabolomic profiles before and after the 14 days chronic feeding trial intervention will be determined and compared. the calculated sample size was 24 patients with t2d and 24 healthy individuals. the study design for meal challenge test (mct) is a single-blinded, randomized crossover trial with 1-week washout period; whereas a case-control design will be used to compare metabolomic profiles of patients with t2d and healthy individuals. the mct model is designed to be high gi (63) and low gi (46) with similar caloric value. during the test day, participants are required to consume the meal within 15 minutes and the blood sample will be taken at the following time points: 0min (fasting), 30, 60, 120, 180 and 240 min. meanwhile, the urine sample will also be collected at 0, 60 and 240 min accordingly. the blood sample will be analyzed for blood glucose, insulin, glp-1, and metabolites; while the urine sample will be analyzed for metabolites. the findings of this study are able to provide fundamental data on metabolic responsiveness of t2d patients following specific meal-plan tailored to malaysian meal pattern using nmr-based metabolomics approach. besides, this study is able to establish a local baseline data of postprandial metabolite profiles of patients with t2d following a specific meal plan. at the same time, this study contributes insight to improve diabetes meal-plan that is friendly to postprandial metabolic perturbations.

Eligibility criteria:
inclusion criteria: * bmi 18.5-35.0 kg/m² * glycemic control (hba1c level 6.5 - 10.0%) * on stabilised oral-antidiabetic drug (oad) : metformin, sulphonylureas, sglt2 inhibitors * estimated glomerular filtration rate (gfr) \>60ml/min * no clinically significant cardiovascular, renal or liver disease exclusion criteria: * smokers * pregnant and lactating women * food allergies or intolerances * on weight loss diet * on insulin therapy * on oad: dpp-4 inhibitors, glp-1 receptor agonists, acarbose * anemia (hb \<10g/dl) * on regular use of hormones or anti-inflammatory medication (aspirin, corticosteroid) * suggestive indicators for impaired thyroid (high t2h level) or liver function

Keywords: glycemic index nmr metabolomics postmeal glucose